Ion Channel Cell Lines | NMI TT Pharmaservices

home contact company.overview news sitemap print privacy



NMI-TT Contact Person

Dr. Timm Danker

+49 7121 51530 896

Ion Channel Cell Lines

Together with our partner, STEINBEIS-INNOVATIONSZENTRUM ZELLKULTURTECHNIK, we develop ion channel cell lines based on the prorietary IGAMI technology.

Theinducible expression device combines two inducible expression systems in one cell. The expression of different gene of interests can be controlled ether by doxycycline (dox-off) or coumermycin (coumermycin-on). After induction the respective transactivator induces the expression of gene of interests as well as its own expression.

This technique has been shown to be an excellent choice for the development of excellent cell lines for difficult targets in ion channel screening.

Our cell lines are optimized for automated patch clamp platforms, like Sophions Qpatch. 

List of ion channel cell lines:

Please contact us if you are interested in customzed ion channel cell line development.


Linked in profile

NMI TT is a subsidiary of NMI